Zhitong Finance App News, Yao Ming Kangde (603259.SH) announced that the Company's wholly-owned subsidiary WuXi PharmaTech Healthcare Fund I L.P. (“WuXi Fund I”) intends to pledge an investment fund share of 5 million US dollars from LONGWOOD SPECIAL FUND, L.P. (“Investment Fund”), accounting for about 4.52% of the share of the raised investment funds. The investment fund is expected to raise no more than US$250 million in total.

According to reports, the investment fund is a limited partnership established under the laws of the US state of Delaware, which mainly focuses on investing in innovative biotechnology companies in pharmaceuticals, treatments, and related fields. This investment fund is a special opportunity fund initiated by Dr. Christoph Westphal's team. It aims to capture scarce value investment opportunities that occurred during the low investment and financing period in the biotechnology industry and provide professional financial support for biotech companies that have shown excellent pre-clinical data or high potential growth period biotechnology companies.